Urenco Group - Publication of Pricing Supplement

Urenco Finance N.V.

18 June 2025

 

URENCO FINANCE N.V.

18 June 2025

Publication of Pricing Supplement

The following Pricing Supplement is available for viewing:

Pricing Supplement dated 16 June 2025 in respect of an issue of €500,000,000 3.625 per cent. Notes due 2035 (the Notes).

The Notes are issued under the €3,000,000,000 Euro Medium Term Note Programme established by Urenco Finance N.V. as Issuer and unconditionally and irrevocably guaranteed on a joint and several basis by Urenco Limited, Urenco UK Limited, Urenco Nederland B.V., Urenco Deutschland GmbH and Louisiana Energy Services, LLC.

The Pricing Supplement in respect of the Notes must be read in conjunction with the Listing Particulars dated 21 May 2025 (the Listing Particulars). Full information on Urenco Finance N.V., and in respect of the offer of the Notes, is only available on the basis of the combination of the Listing Particulars and the Pricing Supplement in respect of the Notes.

To view the Pricing Supplement in respect of the Notes, please paste the URL below into the address bar of your browser:

https://www.urenco.com/investors/financial-information  

For further information, please contact:

Urenco Limited

1 Paddington Square

London

W2 1DL

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Pricing Supplement in respect of the Notes (when read together with the information in the Listing Particulars) may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Listing Particulars) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Pricing Supplement and Listing Particulars is not addressed. Prior to relying on the information contained in the Pricing Supplement and the Listing Particulars you must ascertain whether or not you are part of the intended addressees of the information contained therein.

In particular, the Listing Particulars and the Pricing Supplement in respect of the Notes do not constitute an offer of securities for sale in the United States. The Notes have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, (the Securities Act) or under any relevant securities laws of any state of the United States of America and may not be offered or sold to U.S. persons or to persons within the United States of America except in certain transactions exempt from, or not subject to, the registration requirements of the Securities Act.

Your right to access this service is conditional upon complying with the above requirement.

 

END